Crystalline microspheres and the process of manufacturing the same
Microspheres comprising a core material, wherein the microspheres have a circularity greater than 0.95 and an aspect ratio greater than 0.95, and methods of manufacturing the same. The microspheres may be useful in the manufacture of sustained and modified release active pharmaceutical ingredient (API) microspheres, as a free flowing excipient for mini-tablets and in the manufacture of API dispersions.
1. A microsphere comprising a core material, wherein the microsphere has a circularity greater than 0.95 and an aspect ratio of shortest diameter to longest diameter that is greater than 0.95, wherein the microsphere has a skeletal density from about 1.4595 g/cc to about 1.4651 g/cc, and wherein the microsphere has a moisture gain of less than 1.0% at 90% relative humidity.
2. The microsphere of claim 1 , wherein the microsphere has a mean particle size from about 10 μm to about 500 μm.
3. The microsphere of claim 2 , wherein the microsphere has a mean particle size from about 10 μm to about 20 μm.
4. The microsphere of claim 3 , wherein the microsphere has a moisture content of 0.5% or less.
5. The microsphere of claim 1 , wherein the microsphere has a particle size distribution of 2.8 or less.
6. The microsphere of claim 5 , wherein the microsphere has a particle size distribution of 2.0 or less.
7. The microsphere of claim 5 , wherein the microsphere has a particle size distribution of 1.5 or less.
8. The microsphere of claim 5 , wherein the microsphere has a particle size distribution of 1.0.
9. The microsphere of claim 1 , wherein the microsphere has a moisture content of 0.5% or less.
10. The microsphere of claim 1 , wherein the microsphere is water soluble.
11. The microsphere of claim 1 , wherein the microsphere comprises a single core material.
12. The microsphere of claim 11 , wherein the single core material is mannitol.
13. The microsphere of claim 1 , wherein the microsphere comprises a 100% crystalline core.
14. The microsphere of claim 1 , wherein the microsphere further comprises an active pharmaceutical ingredient.
15. The microsphere of claim 1 , wherein the core material is a polyol.
16. The microsphere of claim 15 , wherein the polyol is mannitol.
17. The microsphere of claim 1 , wherein the microsphere lacks internal voids.
18. A composition comprising the microsphere of claim 1 .
19. The composition of claim 18 , further comprising an active pharmaceutical ingredient.
20. The microsphere of claim 1 , wherein the microsphere lacks porosity.